Page last updated: 2024-11-04

hydroxymethyltolbutamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hydroxymethyltolbutamide: tolbutamide metabolite [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-hydroxytolbutamide : A urea that consists of 1-butylurea having a 4-hydroxymethylbenzenesulfonyl group attached at the 3-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3656
CHEMBL ID3942720
CHEBI ID63799
SCHEMBL ID14067598
MeSH IDM0097752

Synonyms (45)

Synonym
4-hydroxytolbutamide, >=98% (hplc)
5719-85-7
NCGC00165921-01
hydroxytolbutamide
methylhydroxytolbutamide
n-((butylamino)carbonyl)-4-(hydroxymethyl)benzenesulfonamide
1-butyl-3-(4-hydroxymethylphenyl)sulfonylurea
hydroxymethyltolbutamide
4 hydroxy tolbutamide
1-butyl-3-[4-(hydroxymethyl)phenyl]sulfonylurea
52k8j94779 ,
benzenesulfonamide, n-((butylamino)carbonyl)-4-(hydroxymethyl)-
unii-52k8j94779
FT-0670178
FT-0670179
hydroxymethylcarbutamide
hydroxy tolbutamide
1-butyl-3-(p-hydroxymethylphenyl)sulfonylurea
n-(butylaminocarbonyl)-4-hydroxymethylbenzenesulfonamide
CHEBI:63799
4-hydroxytolbutamide
n-(butylcarbamoyl)-4-(hydroxymethyl)benzenesulfonamide
S12366
SCHEMBL14067598
CHEMBL3942720
benzenesulfonamide, n-[(butylamino)carbonyl]-4-(hydroxymethyl)-
1-butyl-3-(p-hydroxymethyl) phenyl sulfonylurea
HMS3650C22
mfcd00144466
DTXSID30205824
3-butyl-1-{[4-(hydroxymethyl)benzene]sulfonyl}urea
4-hydroxy tolbutamide
AKOS030255842
us9333197, 4-hydroxytolbutamide
bdbm224813
HY-100641
CS-0019878
Q27132812
SR-01000946271-1
sr-01000946271
SY013953
4-hydroxy-tolbutamide
3-butyl-1-[4-(hydroxymethyl)benzenesulfonyl]urea
AS-57422
PD020444

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" Noncompartmental pharmacokinetic parameters were calculated using standard equations and compared with those previously reported in Caucasian subjects using the Mann-Whitney U test."( Pharmacokinetics of tolbutamide in ethnic Chinese.
Bridge, S; Gross, AS; Shenfield, GM, 1999
)
0.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
sulfonamideAn amide of a sulfonic acid RS(=O)2NR'2.
ureas
benzyl alcoholsCompounds containing a phenylmethanol skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (5)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase I - Functionalization of compounds69175
Cytochrome P450 - arranged by substrate type30110
Xenobiotics450

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (26.09)18.7374
1990's13 (56.52)18.2507
2000's4 (17.39)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.15 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (8.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]